We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Guidant shareholders overwhelmingly approved the proposed $25.4 billion sale of the Indiana-based devicemaker to Johnson & Johnson (J&J) in a special April 27 meeting.